Abstract : Silencing of gene expression by RNA interference RNAi has become a widely used tool for assessing gene function in a fast and easy manner. An important advance in the RNAi eld was the discovery that plasmid-based short hairpin RNA transcription can substitute for synthetic small interference RNAs both in vitro and in vivo. The constitutive knockdown of gene expression by RNAi can limit the scope of experiments, especially if the inhibition of genes leads to cell lethality, which prevents in vivo functional analysis. We have generated double-conditional short hairpin RNA from a single vector that can regulate its own transcription by a combination of tetracycline-inducible and Cre-loxP systems. This vector will be useful for the control of short hairpin RNA expression in a spatially-regulated manner by Cre recombinase as well as a temporally-regulated manner by tetracycline induction. These control features provide for the speci c silencing of genes to facilitate functional genetic analysis in mammals in vivo.
Introduction
RNA interference RNAi is a posttranscriptional gene silencing phenomenon that is induced by double-stranded RNA dsRNA and was first identified in the nematode, Caenorhabditis elegans 1 .
A member of RNase enzyme family, Dicer, cleaves long dsRNAs introduced into cells during the initial steps of RNAi into small interfering RNAs siRNAs 2 . These siRNA duplexes are unwound by an RNA helicase and are incorporated into the multi-protein RNA-induced silencing complex RISC . Annealing of the siRNA to homologous mRNA results in mRNA degradation and suppression of the target gene expression 3 . This phenomenon is conserved in evolutionarily diverse organisms, but gene silencing by RNAi is difficult to detect in mammalian systems because long dsRNAs result in activation of antiviral pathways, nonspecific inhibition of translation and cytotoxic responses 4 . The use of synthetic 21 25 bp siRNA to down-modulate target genes is one way to circumvent the cytotoxic dsRNA-activated pathways in mammals 5 . Chemically efficacy in gene silencing. The RNA-dependent RNA polymerase protein RdRP , that forms the siRNA-replication systems in fungi, plants and nematodes, is not found in mammals 6 . To overcome this limitation, several mammalian expression vectors have been designed to direct the constitutive synthesis of short hairpin RNAs shRNA as precursors of siRNA-like transcripts 7 .
Most of these vectors have used polymerase pol promoters including the U6, H1, and tRNA promoters, which direct the synthesis of small, noncoding transcripts with 3 -ends defined by termination within a stretch of four to five thymidine residues. This has the advantage of generating higher levels of siRNAs than polymerase pol promoters 8 .
A major limitation of pol promoters is that they do not control silencing in a time-and/or tissue-specific manner because they are constitutively and ubiquitously active, which has limited the scope of experiments, especially if gene silencing results in lethality. Recently developed conditional expression vectors enable the controlled production of shRNAs. These vectors permit similar analytical refinement to conditional gene knockout mice, which utilize either the Cre-loxP recombination system 9 or the tetracycline Tet -regulated system 10 . We have generated novel conditional shRNA vectors that can regulate its silencing in a double conditional manner by the combination of both systems. These vectors will allow spatial and temporal control of shRNA expression in vivo and should facilitate functional genetic analysis in mammals.
Materials and Methods

Generation of plasmids
To generate a double conditional single shRNA plasmid vector, the Cre-loxP conditional system was added to a plasmid containing the Tet-controlled gene silencing system. A plasmid containing the first modified loxP site hereafter termed TATA-lox 11 , followed by the terminator polyA and a SmaI restriction site, was generated using self-ligated PCR-products from the pSingle-tTs-shRNA plasmid vector Clontech, Palo Alto, CA, USA 12 as the template using the following oligonucleotides ; Sma Xho -F, 5 -CCGGGAACGCGCGGTGACCCTCGA GGGACAAGCTTATCTATGTCG-3 , TATALOX1-R, 5 -GAAAAAAACCAAGGCTTATAACTTC GTATAATTTATACTATACGAAGTTATAATTACTTTCAAGTTACGGTAAGCATATG-3 .
The resulting plasmid was digested with Sma and Xho and ligated to the following annealed oligonucleotides ; TATALOX2-F, 5 -GGGAGAGCCTGCAGGATAACTTCGTATAGTAT AAATTATACGAAGTTATAAGC-3 ; TATALOX2-R, 5 -TCGAGCTTATAACTTCGTATAATTT ATACTATACGAAGTTATCCTGCAGGCTCTCCC-3 in order to inset the second TATAlox site preceded by an Sbf restriction site.
The resulting construct was then digested with Sma plus Sbf , and ligated to a DNA cassette containing a Sma restriction site followed by the beta-actin promoter and the SNAPtag-rabbit beta-globin polyadenylation signal followed by an Nsi restriction site to finally generate the pSingle-tTs-2lox shRNA vector.
Cre-mediated DNA recombination
An aliquot of 10 ng of pSingle-tTs-2lox shRNA vector was incubated for 16 h with Cre recombinase New England Biolabs, Inc., Ipswich, MA, USA , according to manufacturer s instructions, in order to excise the stuffer sequence between the two TATAlox sites. The digested vector was transformed into Ecos competent cells of E. coli DH5 Nippon Gene Co., Ltd., Tokyo, Japan and was analyzed by restriction enzyme digestion and DNA sequencing to confirm the sequence of the novel shRNA expression vector. The DNA sequencing reactions were performed in a BioRad DNA Engine Dyad PTC-220 Peltier Thermal Cycler Bio-Rad Laboratories, Inc., Hercules, CA, USA using a ABI BigDye TM Terminator v3.1 Cycle Sequencing
Kit with AmpliTaq DNA polymerase Applied Biosystems, Inc., Foster City, CA, USA , following the protocols supplied by the manufacturer. The sequencing reactions were then subjected to electrophoresis in an ABI 3730xl sequencer Applied Biosystems, Inc. .
Nucleotide sequence analysis
The genetic information software GENETYX version 6, Genetyx Cor., Osaka, Japan was used to design oligonucleotides and for nucleotide sequences analyses.
Cell culture and DNA transfection
Human embryonic kidney 293 HEK293 cells were maintained in Dulbecco s modified Eagle medium Wako Pure Chemicals Industries, Ltd., Osaka, Japan with 10 fetal bovine serum HyClone Lab. Inc., South Logan, UT, USA , and 100 units/mL penicillin, 100 g/mL streptomycin antibiotics Wako Pure Chemicals Industries . HEK293 cells were co-transfected with the shRNA expression vectors containing the shRNA oligonucleotide 5 -TCGAGGCAAG CTGACCCTGAAGTTCTTCAAGAGAGAACTTCAGGGTCAGCTTGCTTTTTTACGCGTA-3 for destabilized2 enhanced green fluorescent protein d2EGFP, antisense nucleotide sequence is underlined 13 and the d2EGFP expression vector Clontech 14 . The cells were plated on polyd-lysine-coated glass-bottomed 35-mm culture dishes MatTek, Ashland, MA, USA and were transfected by the calcium phosphate precipitation method 15 using a Profection Mammalian Transfection System Kit Promega, Madison, WI, USA . Transfected cells were washed 4 h after the transfection and allowed to grow in fresh medium for 24 h. The medium was then replaced with the same growth medium either containing 1 g/mL doxycycline Dox ; Sigma-Aldrich Co., St. Louis, MO, USA to induce the production of shRNA or without Dox as the non-induced control experiments.
Microscopic detection of d2EGFP uorescence
The Dox-induced inhibition of the d2EGFP expression in HEK293 cells was assayed at 48 h after application of Dox. The cells were washed twice with phosphate-buffered saline PBS and fixed with 4 formaldehyde in PBS for 15 in at room temperature. All transfected HEK293 cells were viewed under an inverted fluorescent microscope Eclipse-Ti-U Nikon, Tokyo, Japan equipped with a cooled charge-coupled device camera DS-2MBWc Nikon .
Results
Modified-loxP insertion into Tet-responsive hybrid U6 promoter
The commonly used pol promoter-based shRNA vectors are ubiquitously active and do not allow control of tissue-specific gene silencing. To enable the controlled production of shRNA specifically in a tissue of interest, conditional expression vectors were developed that offer a similar analytical refinement as the conditional knockout mice with the Cre-loxP recombination technologies. Our aim was to modify the commercially-available pSingle-tTs-shRNA vector to control shRNA expression in a Cre-dependent manner.
The U6 promoter is similar to other pol promoters with a compact organization consisting of a tightly spaced TATA box, a proximal sequence element PSE and a distal sequence element DSE . The PSE and the TATA box are absolutely necessary while the DSE is partially dispensable for transcriptional activity 11 . In fact, the pSingle-tTs-shRNA commercially available vector has the PSE and the TATA box in its modified Tet-responsive pol hybrid promoter PTREmodU6 but does not have a DSE. Sequence alignments of the human U6 promoter with Tet-responsive modified U6 promoters are shown in Fig. 1 . The normal spacing between the PSE and the 17-bp TATA box as well as between the TATA box and the 25-bp transcription start site must be preserved, because even small changes in the length of this region markedly impair promoter activity 16 . This consideration precludes the incorporation of an additional classic loxP sequence because the 34-bp loxP site that remains after Cre-mediated recombination would increase the spacing between the TATA box and both the PSE and the transcription start site.
To overcome these limitations, we utilized a bifunctional loxP site, termed the TATA-lox site 11 , which contains a functional TATA box in its spacer region. The insertion of the TATAlox site replaced the TATA box in the PTREmodU6 promoter, and the spacing between the TATA box and both the PSE and the transcription start site is not altered Fig. 2 . Cremediated recombination of this modified vector containing two TATA-lox sites in the same orientation TATA-lox -terminator TTTTTT -stuffer sequence -TATA-lox , termed TATA-2lox resulted in the loss of one Pvu site in the stuffer sequence to yield a recombined sequence, termed TATA-1lox Fig. 3 . DNA sequence analysis confirmed that the spacing between the TATA box and PSE was 17 bp and that between the TATA box and the transcription start site was 25 bp after Cre-mediated recombination Fig. 4 .
To evaluate whether these modified shRNA vectors could functionally regulate conditional gene-silencing abilities, the d2EGFP reporter expression vector was co-transfected into HEK293 cells with the shRNA of vectors TATA-2lox, TATA-1lox or the original pSingle-tTs-shRNA vector containing the shRNA sequence corresponding to the coding region of EGFP. Three days after transfection, a strong green fluorescence signal was observed in many cells, which demonstrated that d2EGFP was efficiently expressed under the control of the CMV promoter. The d2EGFP fluorescent intensity in the cytosol was not decreased in the absence of Dox, in all three combinations of co-transfections 
Discussion
Since the development of gene targeting technologies, the gold standard for the analysis of gene function in mammals has been the generation of gene knockout KO mice 17 . The production of loss-of-function alleles in the mouse remains time consuming and costly despite significant technological improvements. Recently, the constitutive expression of shRNAs driven by pol promoters has been demonstrated to functionally silence gene expression in transgenic mice. This suggests that RNAi-based technologies might represent a convenient alternative to gene targeting through homologous recombination 18 . Current approaches for the use of transgenic RNAi have a major limitation because they result in constitutive gene silencing in all tissues and do not allow regulated expression of shRNA. Improvements in this technology have permitted refined analyses of gene function in specific tissues, based on conditional KO strategies including Cre-loxP-mediated recombination. Transgenic mice produced by this technique can result in early embryonic lethality by the inhibition of gene expression, whereas others show no abnormalities in their general phenotype. This results from compensatory gene induction of one or more genes that act as counterparts to the targeted gene and maintain whole-body homeostasis during growth and/or development. In both cases, an analysis of the role s of genes-of-interest in adult transgenic mice is problematic.
To overcome these difficulties, we have combined a drug-inducible shRNA expression system with the Cre-loxP regulated system 9 17 . In a conventional drug-inducible expression system, such as the Tet inducible system 10 , two kinds of genetic regulatory elements in two distinct vectors must be introduced into an individual cell or body. One is the Tet-responsive element TRE containing minimal CMV promoter, and the other is the gene of Tet repressor TetR gene. The TetR protein blocks transcription by binding to the Tet operator sequences tetO of the TRE in the absence of Tet or its derivatives. The novel vector described here was developed from the commercially available pSingle-tTsshRNA plasmid Clontech 12 . This novel vector has two essential components combined in a single plasmid : 1 CMV promoter/enhancer-controlled expression of the Tet regulatory protein, a transcriptional trans-silencer tTs, and 2 a Tet-inducible shRNA expression cassette including the modified Tet-responsive pol hybrid promoter PTREmodU6 . Therefore, only a single round of gene transfer into the host cells or fertilized eggs is required for drug-inducible gene silencing.
In conclusion, we have constructed a novel single shRNA expression vector for gene silencing that can be double-conditioned by the Tet-inducible system and the Cre-loxP system. The Tet control system can control the onset and termination of genetic manipulations by application of Tet or its derivatives to either cells or animals. The Cre-loxP system can regulate the site of Cre recombinase expression in a tissue-specific manner in transgenic animals by utilizing a tissue-specific promoter. More recently, we have replaced the CMV promoter/enhancer with the human elongation factor 1 alpha EF1
promoter that allows expression of TetR in a variety of mammalian cells, including hematopoietic or stem cells, without the transgene silencing associated with CMV promoter [19] [20] [21] . Transgenic mice with this double conditional shRNA expression vector will be crossed with the genetically engineered mice expressing the Cre-recombinase in a tissue-specific manner to obtain the mice that can express the shRNA for silencing the gene of interest in both spatial tissue-specific and temporal Tet-inducible manners. We anticipate that genetically engineered mice with this double conditional shRNA expression system will be exceptionally useful for investigating the functional roles of gene of interest in vivo.
